CovidStanfordV1, Main, Exploration, bibRecord, 000260

Supporting Clinical Decision-Making during the SARS-CoV-2 Pandemic through a Global Research Commitment: The TERAVOLT Experience.

Identifieur interne : 000260 ( Main/Exploration ); précédent : 000259; suivant : 000261

Supporting Clinical Decision-Making during the SARS-CoV-2 Pandemic through a Global Research Commitment: The TERAVOLT Experience.

Auteurs : Annalisa Trama [Italie] ; Claudia Proto [Italie] ; Jennifer G. Whisenant [États-Unis] ; Valter Torri [Italie] ; Alessio Cortellini [Italie] ; Olivier Michielin [Suisse] ; Fabrice Barlesi [France] ; Anne-Marie C. Dingemans [Pays-Bas] ; Jan Van Meerbeeck [Belgique] ; Vera Pancaldi [Espagne] ; Julien Mazieres [France] ; Ross A. Soo [Singapour] ; Natasha B. Leighl [Canada] ; Solange Peters [Suisse] ; Heather Wakelee [États-Unis] ; Leora Horn [États-Unis] ; Matthew Hellmann [États-Unis] ; Selina K. Wong [États-Unis] ; Marina Chiara Garassino [Italie] ; Javier Baena [Espagne]

Source :

Cancer cell [ 1878-3686 ] ; 2020.

RBID : pubmed:33091381

Descripteurs français

KwdFr :
- Betacoronavirus (isolement et purification), Charge mondiale de morbidité (normes), Coopération internationale (MeSH), Enregistrements (MeSH), Guides de bonnes pratiques cliniques comme sujet (normes), Humains (MeSH), Infections à coronavirus (complications), Infections à coronavirus (virologie), Pandémies (MeSH), Pneumopathie virale (complications), Pneumopathie virale (virologie), Prise de décision clinique (MeSH), Tumeurs du thorax (thérapie), Tumeurs du thorax (virologie), Tumeurs du thorax (épidémiologie).
MESH :
- isolement et purification : Betacoronavirus.
- normes : Charge mondiale de morbidité, Guides de bonnes pratiques cliniques comme sujet.
- thérapie : Tumeurs du thorax.
- virologie : Infections à coronavirus, Pneumopathie virale, Tumeurs du thorax.
- épidémiologie : Tumeurs du thorax.
- complications : Coopération internationale, Enregistrements, Humains, Infections à coronavirus, Pandémies, Pneumopathie virale, Prise de décision clinique.

English descriptors

KwdEn :
- Betacoronavirus (isolation & purification), COVID-19 (MeSH), Clinical Decision-Making (MeSH), Coronavirus Infections (complications), Coronavirus Infections (virology), Global Burden of Disease (standards), Humans (MeSH), International Cooperation (MeSH), Pandemics (MeSH), Pneumonia, Viral (complications), Pneumonia, Viral (virology), Practice Guidelines as Topic (standards), Registries (MeSH), SARS-CoV-2 (MeSH), Thoracic Neoplasms (epidemiology), Thoracic Neoplasms (therapy), Thoracic Neoplasms (virology).
MESH :
- complications : Coronavirus Infections, Pneumonia, Viral.
- epidemiology : Thoracic Neoplasms.
- isolation & purification : Betacoronavirus.
- standards : Global Burden of Disease, Practice Guidelines as Topic.
- therapy : Thoracic Neoplasms.
- virology : Coronavirus Infections, Pneumonia, Viral, Thoracic Neoplasms.
- COVID-19, Clinical Decision-Making, Humans, International Cooperation, Pandemics, Registries, SARS-CoV-2.

Abstract

To understand the real impact of COVID-19 on cancer patients, an entirely new data collection effort was initiated within the Thoracic Cancers International COVID-19 Collaboration (TERAVOLT). TERAVOLT reported high mortality related to COVID-19 infection in thoracic cancer patients and identified several negative prognostic factors. In this commentary, we discuss the importance and limits of patient registries to support decision-making in thoracic cancer during the SARS-CoV-2 pandemic.

DOI: 10.1016/j.ccell.2020.10.002
PubMed: 33091381
PubMed Central: PMC7534826

Affiliations:

Links toward previous steps (curation, corpus...)

to stream Main, to step Corpus: 000229
to stream Main, to step Curation: 000229

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Supporting Clinical Decision-Making during the SARS-CoV-2 Pandemic through a Global Research Commitment: The TERAVOLT Experience.</title>
<author><name sortKey="Trama, Annalisa" sort="Trama, Annalisa" uniqKey="Trama A" first="Annalisa" last="Trama">Annalisa Trama</name>
<affiliation wicri:level="3"><nlm:affiliation>Department of Research, Evaluative Epidemiology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.</nlm:affiliation>
<country xml:lang="fr">Italie</country>
<wicri:regionArea>Department of Research, Evaluative Epidemiology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan</wicri:regionArea>
<placeName><settlement type="city">Milan</settlement>
<region nuts="2">Lombardie</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Proto, Claudia" sort="Proto, Claudia" uniqKey="Proto C" first="Claudia" last="Proto">Claudia Proto</name>
<affiliation wicri:level="3"><nlm:affiliation>Thoracic Oncology Unit, Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.</nlm:affiliation>
<country xml:lang="fr">Italie</country>
<wicri:regionArea>Thoracic Oncology Unit, Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan</wicri:regionArea>
<placeName><settlement type="city">Milan</settlement>
<region nuts="2">Lombardie</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Whisenant, Jennifer G" sort="Whisenant, Jennifer G" uniqKey="Whisenant J" first="Jennifer G" last="Whisenant">Jennifer G. Whisenant</name>
<affiliation wicri:level="2"><nlm:affiliation>Department of Medicine, Division of Hematology & Oncology, Vanderbilt University Medical Center, Nashville, TN, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Medicine, Division of Hematology & Oncology, Vanderbilt University Medical Center, Nashville, TN</wicri:regionArea>
<placeName><region type="state">Tennessee</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Torri, Valter" sort="Torri, Valter" uniqKey="Torri V" first="Valter" last="Torri">Valter Torri</name>
<affiliation wicri:level="3"><nlm:affiliation>Laboratory of Clinical Research, Methodology Oncology Department "Mario Negri" Institute of Pharmacological Researches, IRCCS, Milan, Italy.</nlm:affiliation>
<country xml:lang="fr">Italie</country>
<wicri:regionArea>Laboratory of Clinical Research, Methodology Oncology Department "Mario Negri" Institute of Pharmacological Researches, IRCCS, Milan</wicri:regionArea>
<placeName><settlement type="city">Milan</settlement>
<region nuts="2">Lombardie</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Cortellini, Alessio" sort="Cortellini, Alessio" uniqKey="Cortellini A" first="Alessio" last="Cortellini">Alessio Cortellini</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Biotechnology and Applied Clinical Science, University of L'Aquila, L'Aquila, Italy.</nlm:affiliation>
<country xml:lang="fr">Italie</country>
<wicri:regionArea>Department of Biotechnology and Applied Clinical Science, University of L'Aquila, L'Aquila</wicri:regionArea>
<wicri:noRegion>L'Aquila</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Michielin, Olivier" sort="Michielin, Olivier" uniqKey="Michielin O" first="Olivier" last="Michielin">Olivier Michielin</name>
<affiliation wicri:level="3"><nlm:affiliation>Oncology Department, Lausanne University Hospital (CHUV), Lausanne, Switzerland.</nlm:affiliation>
<country xml:lang="fr">Suisse</country>
<wicri:regionArea>Oncology Department, Lausanne University Hospital (CHUV), Lausanne</wicri:regionArea>
<placeName><settlement type="city">Lausanne</settlement>
<region nuts="3" type="region">Canton de Vaud</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Barlesi, Fabrice" sort="Barlesi, Fabrice" uniqKey="Barlesi F" first="Fabrice" last="Barlesi">Fabrice Barlesi</name>
<affiliation wicri:level="3"><nlm:affiliation>Gustave Roussy Cancer Center, Villejuif, France; Aix Marseille University, CNRS, INSERM, CRCM, Marseille, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Gustave Roussy Cancer Center, Villejuif, France; Aix Marseille University, CNRS, INSERM, CRCM, Marseille</wicri:regionArea>
<placeName><region type="region">Provence-Alpes-Côte d'Azur</region>
<region type="old region">Provence-Alpes-Côte d'Azur</region>
<settlement type="city">Marseille</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Dingemans, Anne Marie C" sort="Dingemans, Anne Marie C" uniqKey="Dingemans A" first="Anne-Marie C" last="Dingemans">Anne-Marie C. Dingemans</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Pulmonology, Erasmus University Medical Center, Rotterdam, and University Maastricht, Maastricht, the Netherlands.</nlm:affiliation>
<country xml:lang="fr" wicri:curation="lc">Pays-Bas</country>
<wicri:regionArea>Department of Pulmonology, Erasmus University Medical Center, Rotterdam, and University Maastricht, Maastricht</wicri:regionArea>
<wicri:noRegion>Maastricht</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Van Meerbeeck, Jan" sort="Van Meerbeeck, Jan" uniqKey="Van Meerbeeck J" first="Jan" last="Van Meerbeeck">Jan Van Meerbeeck</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Pulmonology and Thoracic Oncology, Antwerp University Hospital, Edegem, Belgium.</nlm:affiliation>
<country xml:lang="fr">Belgique</country>
<wicri:regionArea>Department of Pulmonology and Thoracic Oncology, Antwerp University Hospital, Edegem</wicri:regionArea>
<wicri:noRegion>Edegem</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Pancaldi, Vera" sort="Pancaldi, Vera" uniqKey="Pancaldi V" first="Vera" last="Pancaldi">Vera Pancaldi</name>
<affiliation wicri:level="3"><nlm:affiliation>University Paul Sabatier, Toulouse, Inserm, Centre de Recherche en Cancérologie de Toulouse, Toulouse, France; Barcelona Supercomputing Center, Barcelona.</nlm:affiliation>
<country>Espagne</country>
<placeName><settlement type="city">Barcelone</settlement>
<region nuts="2" type="region">Catalogne</region>
</placeName>
<wicri:orgArea>University Paul Sabatier, Toulouse, Inserm, Centre de Recherche en Cancérologie de Toulouse, Toulouse, France; Barcelona Supercomputing Center</wicri:orgArea>
</affiliation>
</author>
<author><name sortKey="Mazieres, Julien" sort="Mazieres, Julien" uniqKey="Mazieres J" first="Julien" last="Mazieres">Julien Mazieres</name>
<affiliation wicri:level="3"><nlm:affiliation>Institut Universitaire du Cancer, Centre Hospitalier Universitaire, Toulouse, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Institut Universitaire du Cancer, Centre Hospitalier Universitaire, Toulouse</wicri:regionArea>
<placeName><region type="region">Occitanie (région administrative)</region>
<region type="old region">Midi-Pyrénées</region>
<settlement type="city">Toulouse</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Soo, Ross A" sort="Soo, Ross A" uniqKey="Soo R" first="Ross A" last="Soo">Ross A. Soo</name>
<affiliation wicri:level="1"><nlm:affiliation>National University Cancer Institute, Singapore.</nlm:affiliation>
<country xml:lang="fr">Singapour</country>
<wicri:regionArea>National University Cancer Institute</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Leighl, Natasha B" sort="Leighl, Natasha B" uniqKey="Leighl N" first="Natasha B" last="Leighl">Natasha B. Leighl</name>
<affiliation wicri:level="3"><nlm:affiliation>Princess Margaret Cancer Centre, Toronto, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Princess Margaret Cancer Centre, Toronto</wicri:regionArea>
<placeName><settlement type="city">Toronto</settlement>
<region type="state">Ontario</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Peters, Solange" sort="Peters, Solange" uniqKey="Peters S" first="Solange" last="Peters">Solange Peters</name>
<affiliation wicri:level="3"><nlm:affiliation>Oncology Department, Lausanne University Hospital (CHUV), Lausanne, Switzerland.</nlm:affiliation>
<country xml:lang="fr">Suisse</country>
<wicri:regionArea>Oncology Department, Lausanne University Hospital (CHUV), Lausanne</wicri:regionArea>
<placeName><settlement type="city">Lausanne</settlement>
<region nuts="3" type="region">Canton de Vaud</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Wakelee, Heather" sort="Wakelee, Heather" uniqKey="Wakelee H" first="Heather" last="Wakelee">Heather Wakelee</name>
<affiliation wicri:level="4"><nlm:affiliation>Department of Medicine, Division of Oncology, Stanford University, Stanford, CA, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Medicine, Division of Oncology, Stanford University, Stanford, CA</wicri:regionArea>
<placeName><region type="state">Californie</region>
<settlement type="city">Stanford (Californie)</settlement>
</placeName>
<orgName type="university">Université Stanford</orgName>
</affiliation>
</author>
<author><name sortKey="Horn, Leora" sort="Horn, Leora" uniqKey="Horn L" first="Leora" last="Horn">Leora Horn</name>
<affiliation wicri:level="2"><nlm:affiliation>Department of Medicine, Division of Hematology & Oncology, Vanderbilt University Medical Center, Nashville, TN, USA; Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Medicine, Division of Hematology & Oncology, Vanderbilt University Medical Center, Nashville, TN, USA; Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN</wicri:regionArea>
<placeName><region type="state">Tennessee</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Hellmann, Matthew" sort="Hellmann, Matthew" uniqKey="Hellmann M" first="Matthew" last="Hellmann">Matthew Hellmann</name>
<affiliation wicri:level="2"><nlm:affiliation>Medical Oncology, Memorial Sloan Kettering Evelyn H. Lauder Breast Center, New York, NY, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Medical Oncology, Memorial Sloan Kettering Evelyn H. Lauder Breast Center, New York, NY</wicri:regionArea>
<placeName><region type="state">État de New York</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Wong, Selina K" sort="Wong, Selina K" uniqKey="Wong S" first="Selina K" last="Wong">Selina K. Wong</name>
<affiliation wicri:level="2"><nlm:affiliation>Department of Medicine, Division of Hematology & Oncology, Vanderbilt University Medical Center, Nashville, TN, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Medicine, Division of Hematology & Oncology, Vanderbilt University Medical Center, Nashville, TN</wicri:regionArea>
<placeName><region type="state">Tennessee</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Garassino, Marina Chiara" sort="Garassino, Marina Chiara" uniqKey="Garassino M" first="Marina Chiara" last="Garassino">Marina Chiara Garassino</name>
<affiliation wicri:level="3"><nlm:affiliation>Thoracic Oncology Unit, Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. Electronic address: marina.garassino@istitutotumori.mi.it.</nlm:affiliation>
<country xml:lang="fr">Italie</country>
<wicri:regionArea>Thoracic Oncology Unit, Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan</wicri:regionArea>
<placeName><settlement type="city">Milan</settlement>
<region nuts="2">Lombardie</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Baena, Javier" sort="Baena, Javier" uniqKey="Baena J" first="Javier" last="Baena">Javier Baena</name>
<affiliation wicri:level="3"><nlm:affiliation>Medical Oncology Department, Thoracic Cancer and Early Drug Development Unit, Hospital Universitario 12 de Octubre, Madrid, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Medical Oncology Department, Thoracic Cancer and Early Drug Development Unit, Hospital Universitario 12 de Octubre, Madrid</wicri:regionArea>
<placeName><settlement type="city">Madrid</settlement>
<region nuts="2" type="region">Communauté de Madrid</region>
</placeName>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2020">2020</date>
<idno type="RBID">pubmed:33091381</idno>
<idno type="pmid">33091381</idno>
<idno type="doi">10.1016/j.ccell.2020.10.002</idno>
<idno type="pmc">PMC7534826</idno>
<idno type="wicri:Area/Main/Corpus">000229</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000229</idno>
<idno type="wicri:Area/Main/Curation">000229</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000229</idno>
<idno type="wicri:Area/Main/Exploration">000229</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Supporting Clinical Decision-Making during the SARS-CoV-2 Pandemic through a Global Research Commitment: The TERAVOLT Experience.</title>
<author><name sortKey="Trama, Annalisa" sort="Trama, Annalisa" uniqKey="Trama A" first="Annalisa" last="Trama">Annalisa Trama</name>
<affiliation wicri:level="3"><nlm:affiliation>Department of Research, Evaluative Epidemiology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.</nlm:affiliation>
<country xml:lang="fr">Italie</country>
<wicri:regionArea>Department of Research, Evaluative Epidemiology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan</wicri:regionArea>
<placeName><settlement type="city">Milan</settlement>
<region nuts="2">Lombardie</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Proto, Claudia" sort="Proto, Claudia" uniqKey="Proto C" first="Claudia" last="Proto">Claudia Proto</name>
<affiliation wicri:level="3"><nlm:affiliation>Thoracic Oncology Unit, Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.</nlm:affiliation>
<country xml:lang="fr">Italie</country>
<wicri:regionArea>Thoracic Oncology Unit, Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan</wicri:regionArea>
<placeName><settlement type="city">Milan</settlement>
<region nuts="2">Lombardie</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Whisenant, Jennifer G" sort="Whisenant, Jennifer G" uniqKey="Whisenant J" first="Jennifer G" last="Whisenant">Jennifer G. Whisenant</name>
<affiliation wicri:level="2"><nlm:affiliation>Department of Medicine, Division of Hematology & Oncology, Vanderbilt University Medical Center, Nashville, TN, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Medicine, Division of Hematology & Oncology, Vanderbilt University Medical Center, Nashville, TN</wicri:regionArea>
<placeName><region type="state">Tennessee</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Torri, Valter" sort="Torri, Valter" uniqKey="Torri V" first="Valter" last="Torri">Valter Torri</name>
<affiliation wicri:level="3"><nlm:affiliation>Laboratory of Clinical Research, Methodology Oncology Department "Mario Negri" Institute of Pharmacological Researches, IRCCS, Milan, Italy.</nlm:affiliation>
<country xml:lang="fr">Italie</country>
<wicri:regionArea>Laboratory of Clinical Research, Methodology Oncology Department "Mario Negri" Institute of Pharmacological Researches, IRCCS, Milan</wicri:regionArea>
<placeName><settlement type="city">Milan</settlement>
<region nuts="2">Lombardie</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Cortellini, Alessio" sort="Cortellini, Alessio" uniqKey="Cortellini A" first="Alessio" last="Cortellini">Alessio Cortellini</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Biotechnology and Applied Clinical Science, University of L'Aquila, L'Aquila, Italy.</nlm:affiliation>
<country xml:lang="fr">Italie</country>
<wicri:regionArea>Department of Biotechnology and Applied Clinical Science, University of L'Aquila, L'Aquila</wicri:regionArea>
<wicri:noRegion>L'Aquila</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Michielin, Olivier" sort="Michielin, Olivier" uniqKey="Michielin O" first="Olivier" last="Michielin">Olivier Michielin</name>
<affiliation wicri:level="3"><nlm:affiliation>Oncology Department, Lausanne University Hospital (CHUV), Lausanne, Switzerland.</nlm:affiliation>
<country xml:lang="fr">Suisse</country>
<wicri:regionArea>Oncology Department, Lausanne University Hospital (CHUV), Lausanne</wicri:regionArea>
<placeName><settlement type="city">Lausanne</settlement>
<region nuts="3" type="region">Canton de Vaud</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Barlesi, Fabrice" sort="Barlesi, Fabrice" uniqKey="Barlesi F" first="Fabrice" last="Barlesi">Fabrice Barlesi</name>
<affiliation wicri:level="3"><nlm:affiliation>Gustave Roussy Cancer Center, Villejuif, France; Aix Marseille University, CNRS, INSERM, CRCM, Marseille, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Gustave Roussy Cancer Center, Villejuif, France; Aix Marseille University, CNRS, INSERM, CRCM, Marseille</wicri:regionArea>
<placeName><region type="region">Provence-Alpes-Côte d'Azur</region>
<region type="old region">Provence-Alpes-Côte d'Azur</region>
<settlement type="city">Marseille</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Dingemans, Anne Marie C" sort="Dingemans, Anne Marie C" uniqKey="Dingemans A" first="Anne-Marie C" last="Dingemans">Anne-Marie C. Dingemans</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Pulmonology, Erasmus University Medical Center, Rotterdam, and University Maastricht, Maastricht, the Netherlands.</nlm:affiliation>
<country xml:lang="fr" wicri:curation="lc">Pays-Bas</country>
<wicri:regionArea>Department of Pulmonology, Erasmus University Medical Center, Rotterdam, and University Maastricht, Maastricht</wicri:regionArea>
<wicri:noRegion>Maastricht</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Van Meerbeeck, Jan" sort="Van Meerbeeck, Jan" uniqKey="Van Meerbeeck J" first="Jan" last="Van Meerbeeck">Jan Van Meerbeeck</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Pulmonology and Thoracic Oncology, Antwerp University Hospital, Edegem, Belgium.</nlm:affiliation>
<country xml:lang="fr">Belgique</country>
<wicri:regionArea>Department of Pulmonology and Thoracic Oncology, Antwerp University Hospital, Edegem</wicri:regionArea>
<wicri:noRegion>Edegem</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Pancaldi, Vera" sort="Pancaldi, Vera" uniqKey="Pancaldi V" first="Vera" last="Pancaldi">Vera Pancaldi</name>
<affiliation wicri:level="3"><nlm:affiliation>University Paul Sabatier, Toulouse, Inserm, Centre de Recherche en Cancérologie de Toulouse, Toulouse, France; Barcelona Supercomputing Center, Barcelona.</nlm:affiliation>
<country>Espagne</country>
<placeName><settlement type="city">Barcelone</settlement>
<region nuts="2" type="region">Catalogne</region>
</placeName>
<wicri:orgArea>University Paul Sabatier, Toulouse, Inserm, Centre de Recherche en Cancérologie de Toulouse, Toulouse, France; Barcelona Supercomputing Center</wicri:orgArea>
</affiliation>
</author>
<author><name sortKey="Mazieres, Julien" sort="Mazieres, Julien" uniqKey="Mazieres J" first="Julien" last="Mazieres">Julien Mazieres</name>
<affiliation wicri:level="3"><nlm:affiliation>Institut Universitaire du Cancer, Centre Hospitalier Universitaire, Toulouse, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Institut Universitaire du Cancer, Centre Hospitalier Universitaire, Toulouse</wicri:regionArea>
<placeName><region type="region">Occitanie (région administrative)</region>
<region type="old region">Midi-Pyrénées</region>
<settlement type="city">Toulouse</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Soo, Ross A" sort="Soo, Ross A" uniqKey="Soo R" first="Ross A" last="Soo">Ross A. Soo</name>
<affiliation wicri:level="1"><nlm:affiliation>National University Cancer Institute, Singapore.</nlm:affiliation>
<country xml:lang="fr">Singapour</country>
<wicri:regionArea>National University Cancer Institute</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Leighl, Natasha B" sort="Leighl, Natasha B" uniqKey="Leighl N" first="Natasha B" last="Leighl">Natasha B. Leighl</name>
<affiliation wicri:level="3"><nlm:affiliation>Princess Margaret Cancer Centre, Toronto, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Princess Margaret Cancer Centre, Toronto</wicri:regionArea>
<placeName><settlement type="city">Toronto</settlement>
<region type="state">Ontario</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Peters, Solange" sort="Peters, Solange" uniqKey="Peters S" first="Solange" last="Peters">Solange Peters</name>
<affiliation wicri:level="3"><nlm:affiliation>Oncology Department, Lausanne University Hospital (CHUV), Lausanne, Switzerland.</nlm:affiliation>
<country xml:lang="fr">Suisse</country>
<wicri:regionArea>Oncology Department, Lausanne University Hospital (CHUV), Lausanne</wicri:regionArea>
<placeName><settlement type="city">Lausanne</settlement>
<region nuts="3" type="region">Canton de Vaud</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Wakelee, Heather" sort="Wakelee, Heather" uniqKey="Wakelee H" first="Heather" last="Wakelee">Heather Wakelee</name>
<affiliation wicri:level="4"><nlm:affiliation>Department of Medicine, Division of Oncology, Stanford University, Stanford, CA, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Medicine, Division of Oncology, Stanford University, Stanford, CA</wicri:regionArea>
<placeName><region type="state">Californie</region>
<settlement type="city">Stanford (Californie)</settlement>
</placeName>
<orgName type="university">Université Stanford</orgName>
</affiliation>
</author>
<author><name sortKey="Horn, Leora" sort="Horn, Leora" uniqKey="Horn L" first="Leora" last="Horn">Leora Horn</name>
<affiliation wicri:level="2"><nlm:affiliation>Department of Medicine, Division of Hematology & Oncology, Vanderbilt University Medical Center, Nashville, TN, USA; Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Medicine, Division of Hematology & Oncology, Vanderbilt University Medical Center, Nashville, TN, USA; Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN</wicri:regionArea>
<placeName><region type="state">Tennessee</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Hellmann, Matthew" sort="Hellmann, Matthew" uniqKey="Hellmann M" first="Matthew" last="Hellmann">Matthew Hellmann</name>
<affiliation wicri:level="2"><nlm:affiliation>Medical Oncology, Memorial Sloan Kettering Evelyn H. Lauder Breast Center, New York, NY, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Medical Oncology, Memorial Sloan Kettering Evelyn H. Lauder Breast Center, New York, NY</wicri:regionArea>
<placeName><region type="state">État de New York</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Wong, Selina K" sort="Wong, Selina K" uniqKey="Wong S" first="Selina K" last="Wong">Selina K. Wong</name>
<affiliation wicri:level="2"><nlm:affiliation>Department of Medicine, Division of Hematology & Oncology, Vanderbilt University Medical Center, Nashville, TN, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Medicine, Division of Hematology & Oncology, Vanderbilt University Medical Center, Nashville, TN</wicri:regionArea>
<placeName><region type="state">Tennessee</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Garassino, Marina Chiara" sort="Garassino, Marina Chiara" uniqKey="Garassino M" first="Marina Chiara" last="Garassino">Marina Chiara Garassino</name>
<affiliation wicri:level="3"><nlm:affiliation>Thoracic Oncology Unit, Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. Electronic address: marina.garassino@istitutotumori.mi.it.</nlm:affiliation>
<country xml:lang="fr">Italie</country>
<wicri:regionArea>Thoracic Oncology Unit, Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan</wicri:regionArea>
<placeName><settlement type="city">Milan</settlement>
<region nuts="2">Lombardie</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Baena, Javier" sort="Baena, Javier" uniqKey="Baena J" first="Javier" last="Baena">Javier Baena</name>
<affiliation wicri:level="3"><nlm:affiliation>Medical Oncology Department, Thoracic Cancer and Early Drug Development Unit, Hospital Universitario 12 de Octubre, Madrid, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Medical Oncology Department, Thoracic Cancer and Early Drug Development Unit, Hospital Universitario 12 de Octubre, Madrid</wicri:regionArea>
<placeName><settlement type="city">Madrid</settlement>
<region nuts="2" type="region">Communauté de Madrid</region>
</placeName>
</affiliation>
</author>
</analytic>
<series><title level="j">Cancer cell</title>
<idno type="eISSN">1878-3686</idno>
<imprint><date when="2020" type="published">2020</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Betacoronavirus (isolation & purification)</term>
<term>COVID-19 (MeSH)</term>
<term>Clinical Decision-Making (MeSH)</term>
<term>Coronavirus Infections (complications)</term>
<term>Coronavirus Infections (virology)</term>
<term>Global Burden of Disease (standards)</term>
<term>Humans (MeSH)</term>
<term>International Cooperation (MeSH)</term>
<term>Pandemics (MeSH)</term>
<term>Pneumonia, Viral (complications)</term>
<term>Pneumonia, Viral (virology)</term>
<term>Practice Guidelines as Topic (standards)</term>
<term>Registries (MeSH)</term>
<term>SARS-CoV-2 (MeSH)</term>
<term>Thoracic Neoplasms (epidemiology)</term>
<term>Thoracic Neoplasms (therapy)</term>
<term>Thoracic Neoplasms (virology)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Betacoronavirus (isolement et purification)</term>
<term>Charge mondiale de morbidité (normes)</term>
<term>Coopération internationale (MeSH)</term>
<term>Enregistrements (MeSH)</term>
<term>Guides de bonnes pratiques cliniques comme sujet (normes)</term>
<term>Humains (MeSH)</term>
<term>Infections à coronavirus (complications)</term>
<term>Infections à coronavirus (virologie)</term>
<term>Pandémies (MeSH)</term>
<term>Pneumopathie virale (complications)</term>
<term>Pneumopathie virale (virologie)</term>
<term>Prise de décision clinique (MeSH)</term>
<term>Tumeurs du thorax (thérapie)</term>
<term>Tumeurs du thorax (virologie)</term>
<term>Tumeurs du thorax (épidémiologie)</term>
</keywords>
<keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Coronavirus Infections</term>
<term>Pneumonia, Viral</term>
</keywords>
<keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Thoracic Neoplasms</term>
</keywords>
<keywords scheme="MESH" qualifier="isolation & purification" xml:lang="en"><term>Betacoronavirus</term>
</keywords>
<keywords scheme="MESH" qualifier="isolement et purification" xml:lang="fr"><term>Betacoronavirus</term>
</keywords>
<keywords scheme="MESH" qualifier="normes" xml:lang="fr"><term>Charge mondiale de morbidité</term>
<term>Guides de bonnes pratiques cliniques comme sujet</term>
</keywords>
<keywords scheme="MESH" qualifier="standards" xml:lang="en"><term>Global Burden of Disease</term>
<term>Practice Guidelines as Topic</term>
</keywords>
<keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Thoracic Neoplasms</term>
</keywords>
<keywords scheme="MESH" qualifier="thérapie" xml:lang="fr"><term>Tumeurs du thorax</term>
</keywords>
<keywords scheme="MESH" qualifier="virologie" xml:lang="fr"><term>Infections à coronavirus</term>
<term>Pneumopathie virale</term>
<term>Tumeurs du thorax</term>
</keywords>
<keywords scheme="MESH" qualifier="virology" xml:lang="en"><term>Coronavirus Infections</term>
<term>Pneumonia, Viral</term>
<term>Thoracic Neoplasms</term>
</keywords>
<keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Tumeurs du thorax</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>COVID-19</term>
<term>Clinical Decision-Making</term>
<term>Humans</term>
<term>International Cooperation</term>
<term>Pandemics</term>
<term>Registries</term>
<term>SARS-CoV-2</term>
</keywords>
<keywords scheme="MESH" qualifier="complications" xml:lang="fr"><term>Coopération internationale</term>
<term>Enregistrements</term>
<term>Humains</term>
<term>Infections à coronavirus</term>
<term>Pandémies</term>
<term>Pneumopathie virale</term>
<term>Prise de décision clinique</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">To understand the real impact of COVID-19 on cancer patients, an entirely new data collection effort was initiated within the Thoracic Cancers International COVID-19 Collaboration (TERAVOLT). TERAVOLT reported high mortality related to COVID-19 infection in thoracic cancer patients and identified several negative prognostic factors. In this commentary, we discuss the importance and limits of patient registries to support decision-making in thoracic cancer during the SARS-CoV-2 pandemic.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">33091381</PMID>
<DateCompleted><Year>2020</Year>
<Month>11</Month>
<Day>30</Day>
</DateCompleted>
<DateRevised><Year>2021</Year>
<Month>01</Month>
<Day>10</Day>
</DateRevised>
<Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1878-3686</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>38</Volume>
<Issue>5</Issue>
<PubDate><Year>2020</Year>
<Month>11</Month>
<Day>09</Day>
</PubDate>
</JournalIssue>
<Title>Cancer cell</Title>
<ISOAbbreviation>Cancer Cell</ISOAbbreviation>
</Journal>
<ArticleTitle>Supporting Clinical Decision-Making during the SARS-CoV-2 Pandemic through a Global Research Commitment: The TERAVOLT Experience.</ArticleTitle>
<Pagination><MedlinePgn>602-604</MedlinePgn>
</Pagination>
<ELocationID EIdType="pii" ValidYN="Y">S1535-6108(20)30496-7</ELocationID>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ccell.2020.10.002</ELocationID>
<Abstract><AbstractText>To understand the real impact of COVID-19 on cancer patients, an entirely new data collection effort was initiated within the Thoracic Cancers International COVID-19 Collaboration (TERAVOLT). TERAVOLT reported high mortality related to COVID-19 infection in thoracic cancer patients and identified several negative prognostic factors. In this commentary, we discuss the importance and limits of patient registries to support decision-making in thoracic cancer during the SARS-CoV-2 pandemic.</AbstractText>
<CopyrightInformation>Copyright © 2020 Elsevier Inc. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Trama</LastName>
<ForeName>Annalisa</ForeName>
<Initials>A</Initials>
<AffiliationInfo><Affiliation>Department of Research, Evaluative Epidemiology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Proto</LastName>
<ForeName>Claudia</ForeName>
<Initials>C</Initials>
<AffiliationInfo><Affiliation>Thoracic Oncology Unit, Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Whisenant</LastName>
<ForeName>Jennifer G</ForeName>
<Initials>JG</Initials>
<AffiliationInfo><Affiliation>Department of Medicine, Division of Hematology & Oncology, Vanderbilt University Medical Center, Nashville, TN, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Torri</LastName>
<ForeName>Valter</ForeName>
<Initials>V</Initials>
<AffiliationInfo><Affiliation>Laboratory of Clinical Research, Methodology Oncology Department "Mario Negri" Institute of Pharmacological Researches, IRCCS, Milan, Italy.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Cortellini</LastName>
<ForeName>Alessio</ForeName>
<Initials>A</Initials>
<AffiliationInfo><Affiliation>Department of Biotechnology and Applied Clinical Science, University of L'Aquila, L'Aquila, Italy.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Michielin</LastName>
<ForeName>Olivier</ForeName>
<Initials>O</Initials>
<AffiliationInfo><Affiliation>Oncology Department, Lausanne University Hospital (CHUV), Lausanne, Switzerland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Barlesi</LastName>
<ForeName>Fabrice</ForeName>
<Initials>F</Initials>
<AffiliationInfo><Affiliation>Gustave Roussy Cancer Center, Villejuif, France; Aix Marseille University, CNRS, INSERM, CRCM, Marseille, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Dingemans</LastName>
<ForeName>Anne-Marie C</ForeName>
<Initials>AC</Initials>
<AffiliationInfo><Affiliation>Department of Pulmonology, Erasmus University Medical Center, Rotterdam, and University Maastricht, Maastricht, the Netherlands.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Van Meerbeeck</LastName>
<ForeName>Jan</ForeName>
<Initials>J</Initials>
<AffiliationInfo><Affiliation>Department of Pulmonology and Thoracic Oncology, Antwerp University Hospital, Edegem, Belgium.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Pancaldi</LastName>
<ForeName>Vera</ForeName>
<Initials>V</Initials>
<AffiliationInfo><Affiliation>University Paul Sabatier, Toulouse, Inserm, Centre de Recherche en Cancérologie de Toulouse, Toulouse, France; Barcelona Supercomputing Center, Barcelona.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Mazieres</LastName>
<ForeName>Julien</ForeName>
<Initials>J</Initials>
<AffiliationInfo><Affiliation>Institut Universitaire du Cancer, Centre Hospitalier Universitaire, Toulouse, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Soo</LastName>
<ForeName>Ross A</ForeName>
<Initials>RA</Initials>
<AffiliationInfo><Affiliation>National University Cancer Institute, Singapore.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Leighl</LastName>
<ForeName>Natasha B</ForeName>
<Initials>NB</Initials>
<AffiliationInfo><Affiliation>Princess Margaret Cancer Centre, Toronto, Canada.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Peters</LastName>
<ForeName>Solange</ForeName>
<Initials>S</Initials>
<AffiliationInfo><Affiliation>Oncology Department, Lausanne University Hospital (CHUV), Lausanne, Switzerland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Wakelee</LastName>
<ForeName>Heather</ForeName>
<Initials>H</Initials>
<AffiliationInfo><Affiliation>Department of Medicine, Division of Oncology, Stanford University, Stanford, CA, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Horn</LastName>
<ForeName>Leora</ForeName>
<Initials>L</Initials>
<AffiliationInfo><Affiliation>Department of Medicine, Division of Hematology & Oncology, Vanderbilt University Medical Center, Nashville, TN, USA; Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Hellmann</LastName>
<ForeName>Matthew</ForeName>
<Initials>M</Initials>
<AffiliationInfo><Affiliation>Medical Oncology, Memorial Sloan Kettering Evelyn H. Lauder Breast Center, New York, NY, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Wong</LastName>
<ForeName>Selina K</ForeName>
<Initials>SK</Initials>
<AffiliationInfo><Affiliation>Department of Medicine, Division of Hematology & Oncology, Vanderbilt University Medical Center, Nashville, TN, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Garassino</LastName>
<ForeName>Marina Chiara</ForeName>
<Initials>MC</Initials>
<AffiliationInfo><Affiliation>Thoracic Oncology Unit, Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. Electronic address: marina.garassino@istitutotumori.mi.it.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Baena</LastName>
<ForeName>Javier</ForeName>
<Initials>J</Initials>
<AffiliationInfo><Affiliation>Medical Oncology Department, Thoracic Cancer and Early Drug Development Unit, Hospital Universitario 12 de Octubre, Madrid, Spain.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2020</Year>
<Month>10</Month>
<Day>05</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>United States</Country>
<MedlineTA>Cancer Cell</MedlineTA>
<NlmUniqueID>101130617</NlmUniqueID>
<ISSNLinking>1535-6108</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000073640" MajorTopicYN="N">Betacoronavirus</DescriptorName>
<QualifierName UI="Q000302" MajorTopicYN="Y">isolation & purification</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000066491" MajorTopicYN="Y">Clinical Decision-Making</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D018352" MajorTopicYN="N">Coronavirus Infections</DescriptorName>
<QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName>
<QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000071219" MajorTopicYN="N">Global Burden of Disease</DescriptorName>
<QualifierName UI="Q000592" MajorTopicYN="Y">standards</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007391" MajorTopicYN="N">International Cooperation</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011024" MajorTopicYN="N">Pneumonia, Viral</DescriptorName>
<QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName>
<QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D017410" MajorTopicYN="N">Practice Guidelines as Topic</DescriptorName>
<QualifierName UI="Q000592" MajorTopicYN="Y">standards</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D012042" MajorTopicYN="N">Registries</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D013899" MajorTopicYN="N">Thoracic Neoplasms</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
<QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName>
<QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName>
</MeshHeading>
</MeshHeadingList>
<CoiStatement>Declaration of Interests C.P. received personal fees from Roche, Lilly, and Bristol-Myers Squibb and grants and travel reimbursement from Merck Sharp & Dohme, Roche, and Bristol-Myers Squibb. A.C. received grant consultancies from BMS, MSD, Astrazeneca, and Roche and speaker’s fees from Astrazeneca, Astellas, and Novartis. O.M. has received grants and personal fees from Bristol Myers Squibb, Merck Sharp & Dohme, Roche, and Amgen and personal fees from Novartis. A.-M.C.D. attended advisory boards and/or provided lectures for Roche, Eli Lilly, Boehringer Ingelheim, Astra Zeneca, Pfizer, BMS, Amgen, Novartis, MSD, Takeda, and Pharmamar, received research support from BMS, AbbVie, and Amgen. R.S. received honoraria from Amgen, Astra-Zeneca, BMS, Boehringer Ingelheim, Lilly, Merck, Novartis, Pfizer, Roche, Taiho, Takeda, and Yuhan and research funding from Astra-Zeneca and Boehringer Ingelheim. N.L. received honoraria (CME lectures) from BMS, Boehringer Ingelheim, and MSD. Institutional research funding has been received from Astra Zeneca, Amgen, Array, Bayer, EMD Serono, Lilly, Roche, Guardant Health, Pfizer, Takeda, MSD. S.P. received education grants, provided consultation, attended advisory boards, and/or provided lectures for Abbvie, Amgen, AstraZeneca, Bayer, Biocartis, Bioinvent, Blueprint Medicines, Boehringer-Ingelheim, Bristol-Myers Squibb, Clovis, Daiichi Sankyo, Debiopharm, Eli Lilly, F. Hoffmann-La Roche, Foundation Medicine, Illumina, Janssen, Merck Sharp and Dohme, Merck Serono, Merrimack, Novartis, Pharma Mar, Pfizer, Regeneron, Sanofi, Seattle Genetics, Takeda, and Vaccibody, from whom she has received honoraria (all fees to institution). H.W. reports honoraria for advisory board participation from AstraZeneca, Blueprint, Xcovery, Janssen, Daiichi Sankyo, Helsinn, and Mirati; publishing fees from UpToDate; and research support paid to institution from ACEA Biosciences, Arrys Therapeutics, AztraZeneca/MedImmune, BMS, Celgene, Clovis Oncology, Exelixis, Genetech/Roche, Lilly, Merck, Novartis, Pfizer, Pharmacyclics, and Xcovery outside the submitted work. L.H. has received grants, personal fees, and travel reimbursement from Xcovery; grants and travel reimbursement from Bristol Myers Squibb; grants from Boheringer/Ingelherim; and personal fees from AstraZeneca, Roche, Incyte, Merck, Pfizer, Xcovery, EMD, Tesaro, AbbVie, Medscape, Physicians Education Resource, Research to Practice, Onclive, Amgen, and Bayer. M.D.H. received research support from Bristol-Myers Squibb; has been a compensated consultant for Merck, Bristol-Myers Squibb, AstraZeneca, Genentech/Roche, Nektar, Syndax, Mirati, Shattuck Labs, Immunai, Blueprint Medicines, Achilles, and Arcus; received travel support/honoraria from AstraZeneca, Eli Lilly, and Bristol-Myers Squibb; has options from Shattuck Labs, Immunai, and Arcus; and has a patent filed by his institution related to the use of tumor mutation burden to predict response to immunotherapy (PCT/US2015/062208), which has received licensing fees from PGDx. M.C.G. received grants, personal fees, and other financial support from Merck Sharp & Dohme, AstraZeneca, Novartis, Roche, Pfizer, Celgene; grants and other financial support from Tiziana Sciences, Clovis, GlaxoSmithKline, Spectrum, and Blueprint; personal fees and other financial support from Eli Lilly and Bristol Myers Squibb; grants from Merck and Bayer; personal fees from Boheringer, Otsuka Pharma, Incyte, Inivata, Takeda, Bayer, Sanofi, Seattle Genetics, and Daichii Sankyo; and other financial support from Merck Serono. J.B. received support for advisory/consultancy from Astra Zeneca, honoraria (self), and travel and accommodation expenses from Angelini.</CoiStatement>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2020</Year>
<Month>10</Month>
<Day>23</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2020</Year>
<Month>12</Month>
<Day>1</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2020</Year>
<Month>10</Month>
<Day>22</Day>
<Hour>20</Hour>
<Minute>11</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">33091381</ArticleId>
<ArticleId IdType="pii">S1535-6108(20)30496-7</ArticleId>
<ArticleId IdType="doi">10.1016/j.ccell.2020.10.002</ArticleId>
<ArticleId IdType="pmc">PMC7534826</ArticleId>
</ArticleIdList>
<ReferenceList><Reference><Citation>JAMA. 2020 Mar 17;323(11):1061-1069</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32031570</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lancet. 2020 Jun 20;395(10241):1907-1918</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32473681</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Ann Oncol. 2020 Oct;31(10):1386-1396</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32561401</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Eur J Cancer. 2020 Sep;136:132-139</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32683273</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lancet Oncol. 2020 Jul;21(7):893-903</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32479790</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Cancer Discov. 2020 Jul;10(7):935-941</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32357994</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Physiol Rev. 2020 Oct 1;100(4):1839-1850</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32721181</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lancet Oncol. 2020 Jul;21(7):914-922</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32539942</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Cancer Cell. 2020 Jun 8;37(6):742-745</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32425702</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
<affiliations><list><country><li>Belgique</li>
<li>Canada</li>
<li>Espagne</li>
<li>France</li>
<li>Italie</li>
<li>Pays-Bas</li>
<li>Singapour</li>
<li>Suisse</li>
<li>États-Unis</li>
</country>
<region><li>Californie</li>
<li>Canton de Vaud</li>
<li>Catalogne</li>
<li>Communauté de Madrid</li>
<li>Lombardie</li>
<li>Midi-Pyrénées</li>
<li>Occitanie (région administrative)</li>
<li>Ontario</li>
<li>Provence-Alpes-Côte d'Azur</li>
<li>Tennessee</li>
<li>État de New York</li>
</region>
<settlement><li>Barcelone</li>
<li>Lausanne</li>
<li>Madrid</li>
<li>Marseille</li>
<li>Milan</li>
<li>Stanford (Californie)</li>
<li>Toronto</li>
<li>Toulouse</li>
</settlement>
<orgName><li>Université Stanford</li>
</orgName>
</list>
<tree><country name="Italie"><region name="Lombardie"><name sortKey="Trama, Annalisa" sort="Trama, Annalisa" uniqKey="Trama A" first="Annalisa" last="Trama">Annalisa Trama</name>
</region>
<name sortKey="Cortellini, Alessio" sort="Cortellini, Alessio" uniqKey="Cortellini A" first="Alessio" last="Cortellini">Alessio Cortellini</name>
<name sortKey="Garassino, Marina Chiara" sort="Garassino, Marina Chiara" uniqKey="Garassino M" first="Marina Chiara" last="Garassino">Marina Chiara Garassino</name>
<name sortKey="Proto, Claudia" sort="Proto, Claudia" uniqKey="Proto C" first="Claudia" last="Proto">Claudia Proto</name>
<name sortKey="Torri, Valter" sort="Torri, Valter" uniqKey="Torri V" first="Valter" last="Torri">Valter Torri</name>
</country>
<country name="États-Unis"><region name="Tennessee"><name sortKey="Whisenant, Jennifer G" sort="Whisenant, Jennifer G" uniqKey="Whisenant J" first="Jennifer G" last="Whisenant">Jennifer G. Whisenant</name>
</region>
<name sortKey="Hellmann, Matthew" sort="Hellmann, Matthew" uniqKey="Hellmann M" first="Matthew" last="Hellmann">Matthew Hellmann</name>
<name sortKey="Horn, Leora" sort="Horn, Leora" uniqKey="Horn L" first="Leora" last="Horn">Leora Horn</name>
<name sortKey="Wakelee, Heather" sort="Wakelee, Heather" uniqKey="Wakelee H" first="Heather" last="Wakelee">Heather Wakelee</name>
<name sortKey="Wong, Selina K" sort="Wong, Selina K" uniqKey="Wong S" first="Selina K" last="Wong">Selina K. Wong</name>
</country>
<country name="Suisse"><region name="Canton de Vaud"><name sortKey="Michielin, Olivier" sort="Michielin, Olivier" uniqKey="Michielin O" first="Olivier" last="Michielin">Olivier Michielin</name>
</region>
<name sortKey="Peters, Solange" sort="Peters, Solange" uniqKey="Peters S" first="Solange" last="Peters">Solange Peters</name>
</country>
<country name="France"><region name="Provence-Alpes-Côte d'Azur"><name sortKey="Barlesi, Fabrice" sort="Barlesi, Fabrice" uniqKey="Barlesi F" first="Fabrice" last="Barlesi">Fabrice Barlesi</name>
</region>
<name sortKey="Mazieres, Julien" sort="Mazieres, Julien" uniqKey="Mazieres J" first="Julien" last="Mazieres">Julien Mazieres</name>
</country>
<country name="Pays-Bas"><noRegion><name sortKey="Dingemans, Anne Marie C" sort="Dingemans, Anne Marie C" uniqKey="Dingemans A" first="Anne-Marie C" last="Dingemans">Anne-Marie C. Dingemans</name>
</noRegion>
</country>
<country name="Belgique"><noRegion><name sortKey="Van Meerbeeck, Jan" sort="Van Meerbeeck, Jan" uniqKey="Van Meerbeeck J" first="Jan" last="Van Meerbeeck">Jan Van Meerbeeck</name>
</noRegion>
</country>
<country name="Espagne"><region name="Catalogne"><name sortKey="Pancaldi, Vera" sort="Pancaldi, Vera" uniqKey="Pancaldi V" first="Vera" last="Pancaldi">Vera Pancaldi</name>
</region>
<name sortKey="Baena, Javier" sort="Baena, Javier" uniqKey="Baena J" first="Javier" last="Baena">Javier Baena</name>
</country>
<country name="Singapour"><noRegion><name sortKey="Soo, Ross A" sort="Soo, Ross A" uniqKey="Soo R" first="Ross A" last="Soo">Ross A. Soo</name>
</noRegion>
</country>
<country name="Canada"><region name="Ontario"><name sortKey="Leighl, Natasha B" sort="Leighl, Natasha B" uniqKey="Leighl N" first="Natasha B" last="Leighl">Natasha B. Leighl</name>
</region>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidStanfordV1/Data/Main/Exploration

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000260 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000260 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    CovidStanfordV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:33091381
   |texte=   Supporting Clinical Decision-Making during the SARS-CoV-2 Pandemic through a Global Research Commitment: The TERAVOLT Experience.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:33091381" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a CovidStanfordV1

This area was generated with Dilib version V0.6.38.
Data generation: Tue Feb 2 21:24:25 2021. Site generation: Tue Feb 2 21:26:08 2021

	Serveur d'exploration sur le Covid à Stanford
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration sur le Covid à Stanford

Supporting Clinical Decision-Making during the SARS-CoV-2 Pandemic through a Global Research Commitment: The TERAVOLT Experience.

Supporting Clinical Decision-Making during the SARS-CoV-2 Pandemic through a Global Research Commitment: The TERAVOLT Experience.

Source :

Descripteurs français

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki